Home/Filings/4/0001455244-10-000071
4//SEC Filing

Kalnik Matthew W. 4

Accession 0001455244-10-000071

CIK 0000072444other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 6:42 PM ET

Size

5.0 KB

Accession

0001455244-10-000071

Insider Transaction Report

Form 4
Period: 2010-03-17
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Transactions
  • Sale

    Common Stock

    2010-03-17$5.93/sh9,873$58,54729,650.104 total

Issuer

NABI BIOPHARMACEUTICALS

CIK 0000072444

Entity typeother

Related Parties

1
  • filerCIK 0001459477

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 6:42 PM ET
Size
5.0 KB